WO2023245459A1 - Anti-oxidizing composition comprising a thiopyridinone compound - Google Patents
Anti-oxidizing composition comprising a thiopyridinone compound Download PDFInfo
- Publication number
- WO2023245459A1 WO2023245459A1 PCT/CN2022/100256 CN2022100256W WO2023245459A1 WO 2023245459 A1 WO2023245459 A1 WO 2023245459A1 CN 2022100256 W CN2022100256 W CN 2022100256W WO 2023245459 A1 WO2023245459 A1 WO 2023245459A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl group
- formula
- branched
- linear
- group
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 150000001875 compounds Chemical class 0.000 title claims abstract description 48
- 230000003064 anti-oxidating effect Effects 0.000 title description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 39
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 15
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 15
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 10
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 10
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 35
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 33
- -1 ascorbyl acetate Chemical compound 0.000 claims description 32
- 229920006395 saturated elastomer Polymers 0.000 claims description 31
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 102000011782 Keratins Human genes 0.000 claims description 13
- 108010076876 Keratins Proteins 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- 239000012453 solvate Substances 0.000 claims description 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 12
- 125000006529 (C3-C6) alkyl group Chemical group 0.000 claims description 12
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 11
- 230000003287 optical effect Effects 0.000 claims description 11
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 10
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 9
- 125000004122 cyclic group Chemical group 0.000 claims description 9
- 150000004677 hydrates Chemical class 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 229940026231 erythorbate Drugs 0.000 claims description 6
- 235000010350 erythorbic acid Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 229940125810 compound 20 Drugs 0.000 claims description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 3
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 3
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 3
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 3
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 3
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 3
- 229940072107 ascorbate Drugs 0.000 claims description 3
- 229940067599 ascorbyl glucoside Drugs 0.000 claims description 3
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 3
- 229930016911 cinnamic acid Natural products 0.000 claims description 3
- 235000013985 cinnamic acid Nutrition 0.000 claims description 3
- 239000004318 erythorbic acid Substances 0.000 claims description 3
- 229960002442 glucosamine Drugs 0.000 claims description 3
- 229940026239 isoascorbic acid Drugs 0.000 claims description 3
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 claims description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 3
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 3
- 229960005055 sodium ascorbate Drugs 0.000 claims description 3
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 3
- 239000004320 sodium erythorbate Substances 0.000 claims description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 3
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229940119168 tetrahexyldecyl ascorbate Drugs 0.000 claims description 3
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 2
- 238000004061 bleaching Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 19
- 150000003254 radicals Chemical class 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 7
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 6
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 6
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- 238000005282 brightening Methods 0.000 description 5
- 235000001785 ferulic acid Nutrition 0.000 description 5
- 229940114124 ferulic acid Drugs 0.000 description 5
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000004883 caffeic acid Nutrition 0.000 description 3
- 229940074360 caffeic acid Drugs 0.000 description 3
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 229930015704 phenylpropanoid Natural products 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 150000003973 alkyl amines Chemical group 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 229940093797 bioflavonoids Drugs 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- RGIBXDHONMXTLI-UHFFFAOYSA-N chavicol Chemical compound OC1=CC=C(CC=C)C=C1 RGIBXDHONMXTLI-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- JMFRWRFFLBVWSI-NSCUHMNNSA-N coniferol Chemical compound COC1=CC(\C=C\CO)=CC=C1O JMFRWRFFLBVWSI-NSCUHMNNSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 125000001474 phenylpropanoid group Chemical group 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- LZFOPEXOUVTGJS-ONEGZZNKSA-N trans-sinapyl alcohol Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O LZFOPEXOUVTGJS-ONEGZZNKSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- FDHNLHLOJLLXDH-JIYHLSBYSA-N (e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]prop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C(=O)C(C(=C1)OC)=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 FDHNLHLOJLLXDH-JIYHLSBYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- PBKGYWLWIJLDGZ-UHFFFAOYSA-N 2-(dimethylamino)propan-1-ol Chemical compound OCC(C)N(C)C PBKGYWLWIJLDGZ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- SXFJDZNJHVPHPH-UHFFFAOYSA-N 3-methylpentane-1,5-diol Chemical compound OCCC(C)CCO SXFJDZNJHVPHPH-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- IAZKGRRJAULWNS-UHFFFAOYSA-N Chavicol Natural products OC1=CC=C(CCC=C)C=C1 IAZKGRRJAULWNS-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241001193545 Myrciaria dubia Species 0.000 description 1
- 235000016392 Myrciaria paraensis Nutrition 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BGYHLZZASRKEJE-UHFFFAOYSA-N [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCC(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 BGYHLZZASRKEJE-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- LZFOPEXOUVTGJS-UHFFFAOYSA-N cis-sinapyl alcohol Natural products COC1=CC(C=CCO)=CC(OC)=C1O LZFOPEXOUVTGJS-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229940119526 coniferyl alcohol Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- VOTNXLNTNMCSTJ-UHFFFAOYSA-N ethyl hydrogen sulfite Chemical compound CCOS(O)=O VOTNXLNTNMCSTJ-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940076640 hesperidin methylchalcone Drugs 0.000 description 1
- FDVKPDVESAUTEE-UHFFFAOYSA-N hexane-1,6-diol;2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O.OCCCCCCO FDVKPDVESAUTEE-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QFUDHWDUKUCCHZ-UHFFFAOYSA-N methyl hydrogen sulfite Chemical compound COS(O)=O QFUDHWDUKUCCHZ-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- SSDSCDGVMJFTEQ-UHFFFAOYSA-N octadecyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 SSDSCDGVMJFTEQ-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- XRVQTYPOPTUZRF-UHFFFAOYSA-N phenyl hydrogen sulfite Chemical compound OS(=O)OC1=CC=CC=C1 XRVQTYPOPTUZRF-UHFFFAOYSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Definitions
- the present invention relates to an anti-oxidizing composition
- an anti-oxidizing composition comprising a thiopyridinone compound, which is useful for caring for keratin materials, and in particular the skin.
- thiopyridinone compounds exhibit good depigmenting activity, even at low concentration, see for example WO2012080075 and WO2017/102349.
- the thiopyridinone compound can show strong depigmenting or brightening effects by reducing the production of melanin.
- compositions comprising the components of: A) a compound of formula (I) or (I’) , , which can be deemed as a thiopyridinone compound, or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; B) an antioxidant, comprising ascorbic acid or a stabilized derivative thereof in an amount of at least 5%by weight of the composition, can not only achieve the depigmenting or brightening effect desired, but also promote the antioxidizing effect.
- R 1 denotes a radical chosen from:
- R 2 denotes a radical chosen from:
- R 3 denotes a radical chosen from:
- the compound (I’) is the tautomer form of the compound (I) when a tautomeric equilibrium exists according to the following scheme:
- R 1 represents one hydrogen atom.
- R 1 represents a linear (C 1 -C 10 ) alkyl group or branched (C 3 -C 10 ) alkyl group, especially a linear (C 1 -C 6 ) alkyl group or branched (C 3 -C 6 ) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. Particularly the said alkyl group of R 1 is not substituted.
- R 2 represents one hydrogen atom.
- R 2 represents a linear (C 1 -C 10 ) alkyl group or branched (C 3 -C 10 ) alkyl group, especially a linear (C 1 -C 6 ) alkyl group or branched (C 3 -C 6 ) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group; the said alkyl group of R 2 being not substituted.
- R 2 represents a linear (C 1 -C 10 ) alkyl group or branched (C 3 -C 10 ) alkyl group, especially a linear (C 1 -C 6 ) alkyl group or branched (C 3 -C 6 ) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i) , ii) , iii) and iv) as defined herein before.
- the said alkyl group being substituted by one or two groups selected from i) , ii) and iii) , more preferably by one or two groups selected from i) and iii) , better substituted by one group iii) as carboxy.
- radical R 2 Another variant for radical R 2 is that the said alkyl group being substituted by one group iv) especially substituted by one phenyl group.
- R 2 represents a (C 3 -C 8 ) cycloalkyl group, preferably a (C 5 -C 7 ) cycloalkyl group such cyclohexyl.
- R 2 represents C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals, preferably a phenyl group particularly not substituted.
- R 3 represents a hydrogen atom.
- R 3 represents a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; particularly a linear (C 1 -C 6 ) alkyl group or a branched (C 3 -C 6 ) alkyl group, preferably (C 1 -C 4 ) alkyl group such as methyl group.
- a “saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 -C 12 ” is equivalent to a “linear (C 1 -C 12 ) alkyl or branched (C 3 -C 12 ) alkyl group” which correspond to a saturated C 1 -C 12 linear or branched C 3 -C 12 hydrocarbon based group, and preferably C 1 -C 10 linear or C 3 -C 10 branched hydrocarbon based group, more preferably C 1 -C 6 linear or C 3 -C 6 branched hydrocarbon-based;
- the linear or branched groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl.
- the saturated linear or branched alkyl groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl and octyl, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl.
- ⁇ a saturated hydrocarbonated cyclic C 3 -C 8 group is a mono or bicyclic cycloalkyl group containing from 3 to 8 carbon atoms especially is a monocyclic cycloalkyl group in C5 to C7 such as cyclohexyl group,
- alkoxy radical is an alkyl-oxy radical for which the alkyl radical is a linear or branched C 1 -C 16 and preferentially C 1 -C 8 hydrocarbon-based radical;
- aryl group represents a fused or non-fused monocyclic or bicyclic carbon-based group comprising from 5 to 12 carbon atoms, preferably from 6 to 10 carbon atoms, and in which at least one ring is aromatic; preferentially, the aryl radical is a phenyl, biphenyl, naphthyl, more preferably a phenyl group;
- the salts of the compounds of formula (I) , (I’) , (II) or (II’) as defined herein after comprise the conventional non-toxic salts of said compounds, such as those formed from organic or inorganic acid or from organic or inorganic base.
- a mineral base such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example;
- an organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
- This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and/or oxygen atoms and may thus comprise, for example, one or more alcohol functions; mention may be made in particular of 2-amino-2-methylpropanol, ethanolamine, triethanolamine, 2-dimethylaminopropanol, 2-amino-2- (hydroxymethyl) -1, 3-propanediol and 3- (dimethylamino) propylamine.
- salts of amino acids for instance lysine, arginine, guanidine, glutamic acid and aspartic acid.
- the salts of the compounds of formula (I) or (II) may be chosen from alkali metal or alkaline-earth metal salts such as sodium, potassium, calcium or magnesium salts and ammonium salts.
- organic or inorganic acid salt is more particularly chosen from salts chosen from a salt derived from i) hydrochloric acid HCl, ii) hydrobromic acid HBr, iii) sulfuric acid H 2 SO 4 , iv) alkylsulfonic acids: Alk-S (O) 2 OH such as methanesulfonic acid and ethanesulfonic acid; v) arylsulfonic acids: Ar-S (O) 2 OH such as benzenesulfonic acid and toluenesulfonic acid; vi) citric acid; vii) succinic acid; viii) tartaric acid; ix) lactic acid; x) alkoxysulfinic acids: Alk-O-S (O) OH such as methoxysulfinic acid and ethoxysulfinic acid; xi) aryloxysulfinic acids such as tolueneoxysulfinic acid
- the acceptable solvates of the compounds described in the present invention comprise conventional solvates such as those formed during the preparation of said compounds owing to the presence of solvents. Mention may be made, by way of example, of the solvates due to the presence of water or of linear or branched alcohols, such as ethanol or isopropanol.
- optical isomers are in particular, the enantiomers and the diastereoisomers.
- the “keratin material” is the skin.
- skin we intend all the body skin.
- the keratin material is the face, or the neck, especially the face.
- a numeric range is defined with a lower and an upper limit when needed, such as one or more lower limits and one or more upper limits are given to form a range optionally along with one or more preferred ranges.
- a given range can be defined by selecting a lower limit and an upper limit that define the boundaries of the given range. All ranges defined in this manner are inclusive and combinable, that is, any lower limit can be combined with any upper limit to form a range, as long as the lower and upper limits are provided to modify the same subject. For example, when ranges of 60-110 and 80-120 are listed for a specific subject, it is to be understood that ranges 60-120 and 80-110 are also contemplated and encompassed. Further, if the lower limits listed are 1 and 2 and the upper limits are listed as 3, 4 and 5, the following ranges are all predictable and within the scope of the present disclosure: 1-3, 1-4, 1-5, 2-3, 2-4 and 2-5.
- the present invention provides a composition comprising the components of: A) a compound of formula (I) or (I’) , and B) a specific antioxidant.
- composition according to the invention comprises a compound of formula (I) or (I’) below or tautomer (I’) below or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture, as component A) :
- R 1 denotes a radical chosen from:
- R 2 denotes a radical chosen from:
- R 3 denotes a radical chosen from:
- the compound (I’) is the tautomer form of the compound (I) when a tautomeric equilibrium exists according to the following scheme:
- R 1 represents one hydrogen atom.
- R 1 represents a linear (C 1 -C 10 ) alkyl group or branched (C 3 -C 10 ) alkyl group, especially a linear (C 1 -C 6 ) alkyl group or branched (C 3 -C 6 ) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. Particularly the said alkyl group of R 1 is not substituted.
- R 2 represents one hydrogen atom.
- R 2 represents a linear (C 1 -C 10 ) alkyl group or branched (C 3 -C 10 ) alkyl group, especially a linear (C 1 -C 6 ) alkyl group or branched (C 3 -C 6 ) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group; the said alkyl group of R 2 being not substituted.
- R 2 represents a linear (C 1 -C 10 ) alkyl group or branched (C 3 -C 10 ) alkyl group, especially a linear (C 1 -C 6 ) alkyl group or branched (C 3 -C 6 ) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i) , ii) , iii) and iv) as defined herein before.
- the said alkyl group being substituted by one or two groups selected from i) , ii) and iii) , more preferably by one or two groups selected from i) and iii) , better substituted by one group iii) as carboxy.
- radical R 2 Another variant for radical R 2 is that the said alkyl group being substituted by one group iv) especially substituted by one phenyl group.
- R 2 represents a (C 3 -C 8 ) cycloalkyl group, preferably a (C 5 -C 7 ) cycloalkyl group such cyclohexyl.
- R 2 represents C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals, preferably a phenyl group particularly not substituted.
- R 3 represents a hydrogen atom.
- R 3 represents a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; particularly a linear (C 1 -C 6 ) alkyl group or a branched (C 3 -C 6 ) alkyl group, preferably (C 1 -C 4 ) alkyl group such as methyl group.
- the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture;
- R 1 denotes a radical chosen from:
- R 2 denotes a radical chosen from:
- a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 4 alkoxy radicals such as methoxy;
- R 3 denotes a radical chosen from:
- the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture;
- R 1 denotes a radical chosen from:
- R 2 denotes a radical chosen from:
- R 3 denotes a radical chosen from:
- the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture;
- R 1 is a hydrogen atom
- R 2 denotes a radical chosen from:
- R 2 is even more preferably a saturated hydrocarbonated group linear C 1 -C 4 or branched C 3 -C 4 substituted with one group iii) -C (O) -OR 3 .
- compounds of formula (I) and tautomer (I’) are selected among compounds of formula (II) and also the tautomers thereof, the salts thereof, the solvates thereof and the optical isomers thereof, and the racemates thereof, alone or as a mixture:
- R1 and R3 have the same meaning than for compounds of formula (I) and (I’) and X denotes an alkylene radical- (CH 2 ) n -with n being an integer ranging inclusively from 1 to 10, preferably ranging from 1 to 6, more preferably ranging from 1 to 4, such as 1, preferably R 3 represents a hydrogen atom.
- the following compounds are preferably used and their tautomer or their salts, their optical isomers, racemates, and/o r solvates such as hydrates and the thereof, alone or as a mixture:
- the compound according to the present invention is the following:
- the compound 20, N- [ (2-thioxo-1, 2-dihydropyridin-3-yl) carbonyl] glycine may also be nominated as 3-carboxymethylaminocarbonyl-2-thiopyridinone, is a typical representative of the useful thiopyridinone compounds according to the present invention.
- the component A) , compound may be present in an amount ranging for example from 0.01%to 10%by weight, preferably from 0.1%to 5%by weight, or preferably from 0.5%to 3%by weight, relative to the total weight of the composition.
- composition according to the invention comprises an antioxidant, as component B) .
- vitamin C or stabilized derivatives thereof is particularly useful in component B) .
- the composition comprises essentially vitamin C or stabilized derivatives thereof in component B) .
- vitamin C and derivatives can be used, including ascorbic acid, erythorbic acid, or derivatives, especially stabilized derivatives, thereof, e.g., sodium ascorbate/erythorbate and the fat-soluble ester tetrahexyl decyl ascorbate/erythorbate and ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl glucoside, glucosamine ascorbate, ascorbyl acetate, and the like.
- ascorbic acid erythorbic acid, or derivatives, especially stabilized derivatives, thereof, e.g., sodium ascorbate/erythorbate and the fat-soluble ester tetrahexyl decyl ascorbate/erythorbate and ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl glucoside, glucosamine ascorbate, ascorbyl acetate, and the like.
- the component B) may also comprise an “additional antioxidant” different from vitamin C or derivatives thereof, which may be cinnamic acid or a derivative thereof, e.g., a phenylpropanoid.
- Phenylpropanoids include: cinnamic acid, caffeic acid, ferulic acid, trans-ferulic acid (including its antioxidant pharmacore 2, 6-dihydroxy acetophenome) , 5-hydroxyferic acid, sinapic acid, Coumarin, coniferyl alcohol, sinapyl alcohol, eugenol, Chavicol, baicalein, P-coumaric acid and sinapinic acid.
- phenylpropanoids can neutralize free radicals.
- useful cinnamic acid derivatives may comprise 2-ethylhexyl methoxycinnamate, isopropyl methoxycinnamate, isoamyl methoxycinnamate, diisopropyl methoxycinnamate, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate (Tinogard TT) , octadecyl di-t-butyl-4-hydroxyhydrocinnamate, caffeic acid, ferulic acid. Caffeic acid and ferulic acid may be preferable, and ferulic acid may be more preferable.
- the vitamin C or stabilized derivatives thereof can be present in the composition in an amount of 15%to 30%by weight, or preferably 15%to 20%by weight, relative to the total weight of the composition according to the present invention.
- the “additional antioxidant” can be present in the composition from 0%to 2%by weight, preferably 0%to 1%by weight, or preferably 0.1%to 0.5%by weight, relative to the total weight of the composition according to the present invention.
- composition according to the invention can advantageously comprise at least one medium/solvent, including water and/or organic medium/solvent.
- the composition according to the invention may advantageously comprise water in various amounts.
- a relatively high amount of water may be used.
- water is used in a content of greater than or equal to 40%by weight relative to the total weight of composition.
- the water content in the low viscosity composition according to the invention preferably ranges from 40%to 99%by weight, or preferably from 50%to 90%by weight, or from 60%to 80%by weight, relative to the total weight of the composition.
- the high viscosity composition according to the invention advantageously comprises water in a content of less than or equal to 40%by weight relative to the total weight of composition.
- the water content in the high viscosity composition according to the invention preferably ranges from 10%to 40%by weight, or preferably from 15%to 35%by weight, or from 20%to 30%by weight, relative to the total weight of the composition.
- composition according to the invention may also comprise one or more organic medium/solvents, preferably water-soluble organic medium/solvents (solubility of greater than or equal to 5%in water at 25°C and at atmospheric pressure) .
- organic medium/solvents preferably water-soluble organic medium/solvents (solubility of greater than or equal to 5%in water at 25°C and at atmospheric pressure) .
- organic medium/solvents examples include linear or branched, and preferably saturated, monoalcohols or diols, comprising 2 to 10 carbon atoms, such as ethanol, (iso) propanol, butanol, hexylene glycol (2-methyl-2, 4-pentanediol) , neopentyl glycol and 3-methyl-1, 5-pentanediol, butylene glycol, dipropylene glycol and propylene glycol; aromatic alcohols such as phenylethyl alcohol; polyols containing more than two hydroxyl functions, in particular C3-C6 polyols, such as glycerol; polyol ethers, for instance ethylene glycol monomethyl, monoethyl and monobutyl ether, propylene glycol or ethers thereof, for instance propylene glycol monomethyl ether; and also diethylene glycol alkyl ethers, especially C 1 -C 4 alkyl
- the organic medium/solvents when they are present in an amount ranging from 0.1%to 40%by weight, preferably from 1%to 30%by weight, or from 5%to 20%by weight, relative to the total weight of the composition according to the invention.
- composition according to the present invention can be used for various use, comprising application directly on keratin materials, or use to formulate other cosmetic products, such as body cream and in particular various masks.
- compositions may be incorporated into the composition, or used together with the composition according to the present invention.
- active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier. It is also possible to use enzymes that have activity on the skin.
- active agents there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihistamines, healing agents, corticosteroids, tanning agents, and mixtures thereof.
- the content of the other active agent in the composition according to the present invention may be adjusted as a function of the intended purpose of the kit.
- composition according to the present invention may comprise at least on preservative.
- the preservative useful according to the present invention can be any one conventionally used for cosmetics, in particular for masks.
- the content of the preservative is 0.01%to 5%by weight, preferably 0.01%to 3%by weight, preferably 0.01%to 1%by weight, based on the weight of the composition.
- composition according to the present invention may optionally comprise at least one pH adjuster.
- pH adjusters include, but are not limited to, aminomethyl propanol, aminomethylpropane diol, triethanolamine, triethylamine, citric acid, sodium hydroxide, acetic acid, potassium hydroxide, lactic acid, and any combination thereof.
- the amount of the pH adjuster in the composition according to the present invention can be adjusted and determined by those skilled depending on the pH desired, as long as the amount thereof will not bring other substantially harmful effect.
- the pH adjuster can be present in an amount of 1%to 20%by weight, such as from 5%to 15 %by weight, relative to the total weight of the composition.
- the composition of the present invention may also contain adjuvants which are customary in the cosmetic, pharmaceutical and/or dermatological field depending on the final uses and/or the specific product forms, such as hydrophilic or lipophilic gelling agents, emulsifiers, hydrophilic or lipophilic active agents, fragrances, fillers, odor absorbers and dyes.
- adjuvants which are customary in the cosmetic, pharmaceutical and/or dermatological field depending on the final uses and/or the specific product forms, such as hydrophilic or lipophilic gelling agents, emulsifiers, hydrophilic or lipophilic active agents, fragrances, fillers, odor absorbers and dyes.
- the amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01%to 20%by weight of the total weight of the composition.
- compositions according to the invention can be manufactured by known processes, generally used in the cosmetic or dermatological field.
- composition according to the invention finds its application in a large number of cosmetic treatments for keratin materials such as the skin, the scalp or the mucous membranes (lips) , and more particularly the skin, in particular in the care of the face, to brighten the skin.
- the composition according to the invention may be particularly useful for a mask product.
- the subject of the invention is also a cosmetic process for the care or makeup of keratin materials, comprising the application to the keratin materials of a composition as defined above.
- the subject of the invention is also a non-therapeutic cosmetic process for the care or makeup of keratin materials, comprising the application to the keratin materials of a composition as defined above.
- the invention also relates to the cosmetic use of a composition as defined above, for the care or makeup of keratin materials.
- the subject of the invention is the cosmetic use of a composition as defined above, for the care of the skin, preferably for brightening the skin, and/or reducing or lightening darker and/or more coloured spots on the skin.
- the composition is suitable for the treatment of darker and/or more coloured spots on the skin.
- compositions according to the invention are given by way of illustration and without limitation.
- the compounds are indicated in chemical name or INCI name.
- Compound 20 is synthesized as disclosed in example 2 of patent EP3 390 363.
- compositions/formulas described below are expressed in %by weight, relative to the total weight of each composition/formula, unless otherwise indicated.
- compositions of Ex. 1-Ex. 2 were prepared, from the ingredients indicated in the table 1 below (in which the contents were indicated in%by weight of materials with regard to the total weight of the composition) :
- compositions were prepared by the steps of, taking Ex. 1 as an example:
- compositions of Ex. 1-Ex. 2, as well as comparative compositions of CE. 1-CE. 4, prepared in Example A were evaluated for the anti-oxidant performance by a thin layer squalene oxidation test, comprising the steps of:
- Detection of the response of SQOOH&SQ is a test to measure the antioxidant performance well known in the art. The smaller value of the SQOOH/SQ, the better the antioxidant performance is.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
A composition comprises A) a thiopyridinone compound and B) an antioxidant selected from ascorbic acid or a stabilized derivative thereof in an amount of 15% to 30% by weight of the composition.
Description
The present invention relates to an anti-oxidizing composition comprising a thiopyridinone compound, which is useful for caring for keratin materials, and in particular the skin.
It has always been an ultimate target of the cosmetic filed to deliver products with skin benefits such as hydration, moisturizing, anti-aging, brightening, cleansing, and so on. Brightening of the skin is always high interest of the consumers, especially those who have a dark or dull skin tone. Unfortunately, at various periods of their life, some people see the appearance on their skin, and more in particular on the hands, of darker and/or more colored spots, which give the skin heterogeneity. These spots are in particular due to a high concentration of melanin in the keratinocytes located at the surface of the skin.
It is known that certain thiopyridinone compounds exhibit good depigmenting activity, even at low concentration, see for example WO2012080075 and WO2017/102349. The thiopyridinone compound can show strong depigmenting or brightening effects by reducing the production of melanin.
However, there is still a need in the art for new use of thiopyridinone.
SUMMARY OF THE INVENTION
The inventors have unexpectedly discovered that a composition comprising the components of: A) a compound of formula (I) or (I’) , , which can be deemed as a thiopyridinone compound, or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; B) an antioxidant, comprising ascorbic acid or a stabilized derivative thereof in an amount of at least 5%by weight of the composition, can not only achieve the depigmenting or brightening effect desired, but also promote the antioxidizing effect.
In which Formulas (I) and (I’) :
R
1 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
10 or branched C
3-C
10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:
i) -O-R
3
ii) -S-R
3;
R
2 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated hydrocarbonated group linear C
1-C
12 or branched C
3-C
12 or cyclic C
3-C
8, optionally substituted with one or more groups, which may be identical or different, chosen from:
i) -O-R
3
ii) -S-R
3
iii) -C (O) -O-R
3;
iv) a C
5-C
12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
8 alkoxy radicals;
c) a C
5-C
12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
8 alkoxy radicals
R
3 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
10 or branched C
3-C
10 alkyl group;
The compound (I’) is the tautomer form of the compound (I) when a tautomeric equilibrium exists according to the following scheme:
According to one embodiment of the invention R
1 represents one hydrogen atom.
According to another embodiment of the invention R
1 represents a linear (C
1-C
10) alkyl group or branched (C
3-C
10) alkyl group, especially a linear (C
1-C
6) alkyl group or branched (C
3-C
6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. Particularly the said alkyl group of R
1 is not substituted.
According to one embodiment of the invention R
2 represents one hydrogen atom.
According to another embodiment of the invention R
2 represents a linear (C
1-C
10) alkyl group or branched (C
3-C
10) alkyl group, especially a linear (C
1-C
6) alkyl group or branched (C
3-C
6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group; the said alkyl group of R
2 being not substituted.
According to another embodiment of the invention R
2 represents a linear (C
1-C
10) alkyl group or branched (C
3-C
10) alkyl group, especially a linear (C
1-C
6) alkyl group or branched (C
3-C
6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i) , ii) , iii) and iv) as defined herein before. Preferably the said alkyl group being substituted by one or two groups selected from i) , ii) and iii) , more preferably by one or two groups selected from i) and iii) , better substituted by one group iii) as carboxy.
Another variant for radical R
2 is that the said alkyl group being substituted by one group iv) especially substituted by one phenyl group.
According to another embodiment of the invention R
2 represents a (C
3-C
8) cycloalkyl group, preferably a (C
5-C
7) cycloalkyl group such cyclohexyl.
According to another embodiment of the invention R
2 represents C
5-C
12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
8 alkoxy radicals, preferably a phenyl group particularly not substituted.
According to an embodiment R
3 represents a hydrogen atom.
According to another embodiment R
3 represents a saturated linear C
1-C
10 or branched C
3-C
10 alkyl group; particularly a linear (C
1-C
6) alkyl group or a branched (C
3-C
6) alkyl group, preferably (C
1-C
4) alkyl group such as methyl group.
EMBODIMENTS OF INVENTION
Throughout the description, including the claims, the term "comprising a" should be understood as being synonymous with "comprising at least one" , unless otherwise mentioned. Moreover, the expression "at least one" used in the present description is equivalent to the expression "one or more" .
For the purposes of the present invention, and unless otherwise indicated:
a “saturated hydrocarbonated group linear C
1-C
12 or branched C
3-C
12” is equivalent to a “linear (C
1-C
12) alkyl or branched (C
3-C
12) alkyl group” which correspond to a saturated C
1-C
12 linear or branched C
3-C
12 hydrocarbon based group, and preferably C
1-C
10 linear or C
3-C
10 branched hydrocarbon based group, more preferably C
1-C
6 linear or C
3-C
6 branched hydrocarbon-based; Preferentially, the linear or branched groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl.
More preferentially, the saturated linear or branched alkyl groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl and octyl, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl.
■a saturated hydrocarbonated cyclic C
3-C
8 group is a mono or bicyclic cycloalkyl group containing from 3 to 8 carbon atoms especially is a monocyclic cycloalkyl group in C5 to C7 such as cyclohexyl group,
■an "alkoxy radical" is an alkyl-oxy radical for which the alkyl radical is a linear or branched C
1-C
16 and preferentially C
1-C
8 hydrocarbon-based radical;
■when the alkoxy group is optionally substituted, this implies that the alkyl group is optionally substituted as defined hereinabove;
■an "aryl" group represents a fused or non-fused monocyclic or bicyclic carbon-based group comprising from 5 to 12 carbon atoms, preferably from 6 to 10 carbon atoms, and in which at least one ring is aromatic; preferentially, the aryl radical is a phenyl, biphenyl, naphthyl, more preferably a phenyl group;
■the term "at least one" is equivalent to the term "one or more" ; and
■the term "inclusive" for a range of concentrations means that the limits of that range are included in the defined range.
The salts of the compounds of formula (I) , (I’) , (II) or (II’) as defined herein after comprise the conventional non-toxic salts of said compounds, such as those formed from organic or inorganic acid or from organic or inorganic base.
As salts of the compounds of formula (I) , (I’) , (II) or (II’) mention may be made of:
the salts obtained by addition of the compound of formula (I) or (II) to:
- a mineral base, such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example;
or
- an organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine. This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and/or oxygen atoms and may thus comprise, for example, one or more alcohol functions; mention may be made in particular of 2-amino-2-methylpropanol, ethanolamine, triethanolamine, 2-dimethylaminopropanol, 2-amino-2- (hydroxymethyl) -1, 3-propanediol and 3- (dimethylamino) propylamine.
Mention may also be made of the salts of amino acids, for instance lysine, arginine, guanidine, glutamic acid and aspartic acid. Advantageously, the salts of the compounds of formula (I) or (II) (when it comprises a carboxy group) may be chosen from alkali metal or alkaline-earth metal salts such as sodium, potassium, calcium or magnesium salts and ammonium salts.
■as "organic or inorganic acid salt" is more particularly chosen from salts chosen from a salt derived from i) hydrochloric acid HCl, ii) hydrobromic acid HBr, iii) sulfuric acid H
2SO
4, iv) alkylsulfonic acids: Alk-S (O)
2OH such as methanesulfonic acid and ethanesulfonic acid; v) arylsulfonic acids: Ar-S (O)
2OH such as benzenesulfonic acid and toluenesulfonic acid; vi) citric acid; vii) succinic acid; viii) tartaric acid; ix) lactic acid; x) alkoxysulfinic acids: Alk-O-S (O) OH such as methoxysulfinic acid and ethoxysulfinic acid; xi) aryloxysulfinic acids such as tolueneoxysulfinic acid and phenoxysulfinic acid; xii) phosphoric acid H
3PO
4; xiii) acetic acid CH
3C (O) OH; xiv) triflic acid CF
3SO
3H; and xv) tetrafluoroboric acid HBF
4;
■The acceptable solvates of the compounds described in the present invention comprise conventional solvates such as those formed during the preparation of said compounds owing to the presence of solvents. Mention may be made, by way of example, of the solvates due to the presence of water or of linear or branched alcohols, such as ethanol or isopropanol.
■The optical isomers are in particular, the enantiomers and the diastereoisomers.
Preferably, the “keratin material” according to the present invention is the skin. By “skin” , we intend all the body skin. Still preferably, the keratin material is the face, or the neck, especially the face.
In the application, unless specifically mentioned otherwise, amounts, contents, parts and percentages are expressed on a weight basis.
In the application, a numeric range is defined with a lower and an upper limit when needed, such as one or more lower limits and one or more upper limits are given to form a range optionally along with one or more preferred ranges. A given range can be defined by selecting a lower limit and an upper limit that define the boundaries of the given range. All ranges defined in this manner are inclusive and combinable, that is, any lower limit can be combined with any upper limit to form a range, as long as the lower and upper limits are provided to modify the same subject. For example, when ranges of 60-110 and 80-120 are listed for a specific subject, it is to be understood that ranges 60-120 and 80-110 are also contemplated and encompassed. Further, if the lower limits listed are 1 and 2 and the upper limits are listed as 3, 4 and 5, the following ranges are all predictable and within the scope of the present disclosure: 1-3, 1-4, 1-5, 2-3, 2-4 and 2-5.
Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of components and/or reaction conditions are to be understood as being modified in all instances by the term "about" , with conventionally known meaning in the art, e.g., within 10%of the indicated number (such as "about 10%" means 9%-11 %and "about 2%" means 1.8%-2.2%) .
The present invention provides a composition comprising the components of: A) a compound of formula (I) or (I’) , and B) a specific antioxidant.
Component A)
The composition according to the invention comprises a compound of formula (I) or (I’) below or tautomer (I’) below or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture, as component A) :
In which Formulas (I) and (I’) :
R
1 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
10 or branched C
3-C
10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:
i) -O-R
3
ii) -S-R
3;
R
2 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated hydrocarbonated group linear C
1-C
12 or branched C
3-C
12 or cyclic C
3-C
8, optionally substituted with one or more groups, which may be identical or different, chosen from:
i) -O-R
3
ii) -S-R
3
iii) -C (O) -O-R
3;
iv) a C
5-C
12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
8 alkoxy radicals;
c) a C
5-C
12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
8 alkoxy radicals
R
3 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
10 or branched C
3-C
10 alkyl group;
The compound (I’) is the tautomer form of the compound (I) when a tautomeric equilibrium exists according to the following scheme:
According to one embodiment of the invention R
1 represents one hydrogen atom.
According to another embodiment of the invention R
1 represents a linear (C
1-C
10) alkyl group or branched (C
3-C
10) alkyl group, especially a linear (C
1-C
6) alkyl group or branched (C
3-C
6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. Particularly the said alkyl group of R
1 is not substituted.
According to one embodiment of the invention R
2 represents one hydrogen atom.
According to another embodiment of the invention R
2 represents a linear (C
1-C
10) alkyl group or branched (C
3-C
10) alkyl group, especially a linear (C
1-C
6) alkyl group or branched (C
3-C
6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group; the said alkyl group of R
2 being not substituted.
According to another embodiment of the invention R
2 represents a linear (C
1-C
10) alkyl group or branched (C
3-C
10) alkyl group, especially a linear (C
1-C
6) alkyl group or branched (C
3-C
6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i) , ii) , iii) and iv) as defined herein before. Preferably the said alkyl group being substituted by one or two groups selected from i) , ii) and iii) , more preferably by one or two groups selected from i) and iii) , better substituted by one group iii) as carboxy.
Another variant for radical R
2 is that the said alkyl group being substituted by one group iv) especially substituted by one phenyl group.
According to another embodiment of the invention R
2 represents a (C
3-C
8) cycloalkyl group, preferably a (C
5-C
7) cycloalkyl group such cyclohexyl.
According to another embodiment of the invention R
2 represents C
5-C
12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
8 alkoxy radicals, preferably a phenyl group particularly not substituted.
According to an embodiment R
3 represents a hydrogen atom.
According to another embodiment R
3 represents a saturated linear C
1-C
10 or branched C
3-C
10 alkyl group; particularly a linear (C
1-C
6) alkyl group or a branched (C
3-C
6) alkyl group, preferably (C
1-C
4) alkyl group such as methyl group.
Preferably, the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture;
have the following meanings:
R
1 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
6 or branched C
3-C
6 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:
i) -O-R
3
ii) -S-R
3;
preferably optionally substituted with one or more groups i)
R
2 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated hydrocarbonated group linear C
1-C
10 or branched C
3-C
10 or cyclic C
3-C
8 such as C5-C6, optionally substituted with one or more groups, which may be identical or different, chosen from:
i) -O-R
3
ii) -SR-
3
iii) -C (O) -O-R
3;
iv) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
4 alkoxy radicals such as methoxy;
preferably substituted with one or more groups selected from i) and iii) , preferably iii) such as carboxy
R
3 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
6 or branched C
3-C
6 alkyl group
Preferentially, the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture;
have the following meanings:
R
1 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
4 or branched C
3-C
4 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from i) -OR
3, more preferably not substituted;
R
2 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated hydrocarbonated group linear C
1-C
10 or branched C
3-C
10 or cyclic C
3-C
8 as C5-C6, optionally substituted with one or more groups, which may be identical or different, chosen from:
i) -O-R
3
iii) -C (O) -O-R
3;
iv) a C
5-C
12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C
1-C
4 alkoxy radicals;
R
3 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C
1-C
4 or branched C
3-C
4 alkyl group such as methyl or ethyl.
Preferentially, the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture;
have the following meanings:
R
1 is a hydrogen atom; and
R
2 denotes a radical chosen from:
a) a hydrogen atom;
b) a saturated hydrocarbonated group linear C
1-C
5 or branched C
3-C
5 or cyclic C
3-C
8 as C5-C6, substituted with one or more groups, which may be identical or different, chosen from v) -C (O) -O-R
3, preferably substituted with one group iii) -C (O) -O-R
3;
R
2 is even more preferably a saturated hydrocarbonated group linear C
1-C
4 or branched C
3-C
4 substituted with one group iii) -C (O) -OR
3.
According to another preferred embodiment, compounds of formula (I) and tautomer (I’) are selected among compounds of formula (II) and also the tautomers thereof, the salts thereof, the solvates thereof and the optical isomers thereof, and the racemates thereof, alone or as a mixture:
Formula (II) and (II’) Wherein R1 and R3 have the same meaning than for compounds of formula (I) and (I’) and X denotes an alkylene radical- (CH
2)
n-with n being an integer ranging inclusively from 1 to 10, preferably ranging from 1 to 6, more preferably ranging from 1 to 4, such as 1, preferably R
3 represents a hydrogen atom.
Among the compounds of formula (I) , the following compounds are preferably used and their tautomer or their salts, their optical isomers, racemates, and/o r solvates such as hydrates and the thereof, alone or as a mixture:
Among these compounds, the following compounds are more particularly preferred:
More preferably, among these compounds, the following compounds are more particularly preferred:
Even more preferably, among these compounds, the following compounds are more particularly preferred:
In a most preferred embodiment, the compound according to the present invention is the following:
All compounds can be obtained by chemical method known by man skilled in the art, from commercially available reagents. For example, the synthetic method disclosed in the European patent application EP3 390 363 can be used.
The compound 20, N- [ (2-thioxo-1, 2-dihydropyridin-3-yl) carbonyl] glycine, may also be nominated as 3-carboxymethylaminocarbonyl-2-thiopyridinone, is a typical representative of the useful thiopyridinone compounds according to the present invention.
The component A) , compound, may be present in an amount ranging for example from 0.01%to 10%by weight, preferably from 0.1%to 5%by weight, or preferably from 0.5%to 3%by weight, relative to the total weight of the composition.
Component B) , antioxidant
The composition according to the invention comprises an antioxidant, as component B) .
Without being limited by any known theory, it is surprisingly to discover that for the component A) , vitamin C or stabilized derivatives thereof is particularly useful in component B) .
Thus, according to an embodiment of the invention, the composition comprises essentially vitamin C or stabilized derivatives thereof in component B) .
As a useful antioxidant, vitamin C and derivatives can be used, including ascorbic acid, erythorbic acid, or derivatives, especially stabilized derivatives, thereof, e.g., sodium ascorbate/erythorbate and the fat-soluble ester tetrahexyl decyl ascorbate/erythorbate and ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl glucoside, glucosamine ascorbate, ascorbyl acetate, and the like. In addition, it is also possible to use plants derived from a large amount of vitamin C, such as extracts of Myrciaria dubia, acerola, emblica officinalis, and bioflavonoids from rose hips and citrus, including Water-soluble bioflavonoids such as hesperidin methyl chalcone.
The component B) may also comprise an “additional antioxidant” different from vitamin C or derivatives thereof, which may be cinnamic acid or a derivative thereof, e.g., a phenylpropanoid. Phenylpropanoids include: cinnamic acid, caffeic acid, ferulic acid, trans-ferulic acid (including its antioxidant pharmacore 2, 6-dihydroxy acetophenome) , 5-hydroxyferic acid, sinapic acid, Coumarin, coniferyl alcohol, sinapyl alcohol, eugenol, Chavicol, baicalein, P-coumaric acid and sinapinic acid. Without limiting the mode of action of the present invention, phenylpropanoids can neutralize free radicals.
Amongst others, useful cinnamic acid derivatives may comprise 2-ethylhexyl methoxycinnamate, isopropyl methoxycinnamate, isoamyl methoxycinnamate, diisopropyl methoxycinnamate, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate (Tinogard TT) , octadecyl di-t-butyl-4-hydroxyhydrocinnamate, caffeic acid, ferulic acid. Caffeic acid and ferulic acid may be preferable, and ferulic acid may be more preferable.
According to the present invention, the vitamin C or stabilized derivatives thereof can be present in the composition in an amount of 15%to 30%by weight, or preferably 15%to 20%by weight, relative to the total weight of the composition according to the present invention.
According to an embodiment of the present invention, the “additional antioxidant” can be present in the composition from 0%to 2%by weight, preferably 0%to 1%by weight, or preferably 0.1%to 0.5%by weight, relative to the total weight of the composition according to the present invention.
Medium/solvent
The composition according to the invention can advantageously comprise at least one medium/solvent, including water and/or organic medium/solvent.
Water
The composition according to the invention may advantageously comprise water in various amounts. For low viscosity applications of the composition, e.g., in form of leave-on lotion, a relatively high amount of water may be used. For example, water is used in a content of greater than or equal to 40%by weight relative to the total weight of composition. The water content in the low viscosity composition according to the invention preferably ranges from 40%to 99%by weight, or preferably from 50%to 90%by weight, or from 60%to 80%by weight, relative to the total weight of the composition.
For high viscosity applications of the composition, e.g., in form of leave-on cream, a relatively lower amount of water may be used. The high viscosity composition according to the invention advantageously comprises water in a content of less than or equal to 40%by weight relative to the total weight of composition. The water content in the high viscosity composition according to the invention preferably ranges from 10%to 40%by weight, or preferably from 15%to 35%by weight, or from 20%to 30%by weight, relative to the total weight of the composition.
Organic medium/solvent
The composition according to the invention may also comprise one or more organic medium/solvents, preferably water-soluble organic medium/solvents (solubility of greater than or equal to 5%in water at 25℃ and at atmospheric pressure) .
Examples of the organic medium/solvents that may be mentioned include linear or branched, and preferably saturated, monoalcohols or diols, comprising 2 to 10 carbon atoms, such as ethanol, (iso) propanol, butanol, hexylene glycol (2-methyl-2, 4-pentanediol) , neopentyl glycol and 3-methyl-1, 5-pentanediol, butylene glycol, dipropylene glycol and propylene glycol; aromatic alcohols such as phenylethyl alcohol; polyols containing more than two hydroxyl functions, in particular C3-C6 polyols, such as glycerol; polyol ethers, for instance ethylene glycol monomethyl, monoethyl and monobutyl ether, propylene glycol or ethers thereof, for instance propylene glycol monomethyl ether; and also diethylene glycol alkyl ethers, especially C
1-C
4 alkyl ethers, for instance diethylene glycol monoethyl ether or monobutyl ether, alone or as a mixture.
The organic medium/solvents, when they are present in an amount ranging from 0.1%to 40%by weight, preferably from 1%to 30%by weight, or from 5%to 20%by weight, relative to the total weight of the composition according to the invention.
The composition according to the present invention can be used for various use, comprising application directly on keratin materials, or use to formulate other cosmetic products, such as body cream and in particular various masks.
Accordingly, depending on specific use, various additional components may be incorporated into the composition, or used together with the composition according to the present invention.
Other active agents
It is also possible to use active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier. It is also possible to use enzymes that have activity on the skin.
As other examples of active agents that can be suitable for implementing the present invention there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihistamines, healing agents, corticosteroids, tanning agents, and mixtures thereof.
The content of the other active agent in the composition according to the present invention may be adjusted as a function of the intended purpose of the kit.
Preservative
For use of the present invention, the composition according to the present invention may comprise at least on preservative. The preservative useful according to the present invention can be any one conventionally used for cosmetics, in particular for masks.
Preferably, the content of the preservative is 0.01%to 5%by weight, preferably 0.01%to 3%by weight, preferably 0.01%to 1%by weight, based on the weight of the composition.
pH adjuster
The composition according to the present invention may optionally comprise at least one pH adjuster.
Examples of pH adjusters include, but are not limited to, aminomethyl propanol, aminomethylpropane diol, triethanolamine, triethylamine, citric acid, sodium hydroxide, acetic acid, potassium hydroxide, lactic acid, and any combination thereof.
The amount of the pH adjuster in the composition according to the present invention can be adjusted and determined by those skilled depending on the pH desired, as long as the amount thereof will not bring other substantially harmful effect. For example, the pH adjuster can be present in an amount of 1%to 20%by weight, such as from 5%to 15 %by weight, relative to the total weight of the composition.
Adjuvant
In a known manner, the composition of the present invention may also contain adjuvants which are customary in the cosmetic, pharmaceutical and/or dermatological field depending on the final uses and/or the specific product forms, such as hydrophilic or lipophilic gelling agents, emulsifiers, hydrophilic or lipophilic active agents, fragrances, fillers, odor absorbers and dyes. The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01%to 20%by weight of the total weight of the composition.
These adjuvants and their concentrations must be such that they do not modify the desired property for the composition of the invention.
The compositions according to the invention can be manufactured by known processes, generally used in the cosmetic or dermatological field.
The composition according to the invention finds its application in a large number of cosmetic treatments for keratin materials such as the skin, the scalp or the mucous membranes (lips) , and more particularly the skin, in particular in the care of the face, to brighten the skin. For example, the composition according to the invention may be particularly useful for a mask product.
The subject of the invention is also a cosmetic process for the care or makeup of keratin materials, comprising the application to the keratin materials of a composition as defined above.
The subject of the invention is also a non-therapeutic cosmetic process for the care or makeup of keratin materials, comprising the application to the keratin materials of a composition as defined above.
The invention also relates to the cosmetic use of a composition as defined above, for the care or makeup of keratin materials.
More particularly, the subject of the invention is the cosmetic use of a composition as defined above, for the care of the skin, preferably for brightening the skin, and/or reducing or lightening darker and/or more coloured spots on the skin.
In a particular embodiment, the composition is suitable for the treatment of darker and/or more coloured spots on the skin.
EXAMPLES
The following examples of compositions according to the invention are given by way of illustration and without limitation. The compounds are indicated in chemical name or INCI name.
Compound 20 is synthesized as disclosed in example 2 of patent EP3 390 363.
The ingredient amounts/concentrations in the compositions/formulas described below are expressed in %by weight, relative to the total weight of each composition/formula, unless otherwise indicated.
Example A
The inventive compositions of Ex. 1-Ex. 2, as well as comparative compositions of CE. 1-CE. 4, were prepared, from the ingredients indicated in the table 1 below (in which the contents were indicated in%by weight of materials with regard to the total weight of the composition) :
Table 1
The compositions were prepared by the steps of, taking Ex. 1 as an example:
1) . preparing a water solution of COMPOUND 20 (or ferulic acid) ;
2) . heating the solution with 60℃ for 20mins, then cooling down to room temperature;
3) . adding ascorbic acid and chlorphenesin; and
4) . add potassium hydroxide to adjust PH.
Example B
The inventive compositions of Ex. 1-Ex. 2, as well as comparative compositions of CE. 1-CE. 4, prepared in Example A were evaluated for the anti-oxidant performance by a thin layer squalene oxidation test, comprising the steps of:
1. applying artificial serum on squalene solution;
2. preparing a smoke solution, which was known in the art as an aqueous acetonitrile absorbed with smoke;
3. applying respectively the inventive compositions of Ex. 1-Ex. 2, as well as comparative compositions of CE. 1-CE. 4, and applying the smoke solution (5 plate/composition) , both to glass slide with 2.5cm*2cm sequentially;
4. simulating sunlight (5J/cm
2, 17mins) ;
5. standing by for reaction overnight;
6. cutting glass into pieces, extracting by 5ml MeOH, and vibrating for 1hr;
7. filtering all of the extractions; and
8. detecting the response of SQOOH&SQ by LCMS
Detection of the response of SQOOH&SQ is a test to measure the antioxidant performance well known in the art. The smaller value of the SQOOH/SQ, the better the antioxidant performance is.
The results were given in Table 2 below.
Table 2
Properties | Ex. 1 | Ex. 2 | CE. 1 | CE. 2 | CE. 3 | CE. 4 |
SQOOH/SQ | 9 | 10.2 | 10.8 | 15.9 | 13 | 16 |
Claims (13)
- A composition comprising the components of:A) at least one compound selected from compounds of formula (I) and tautomer of formula (I’) herein below; and their salts, optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture:In which Formulas (I) and (I’) :- R 1 denotes a radical chosen from:a) a hydrogen atom;b) a saturated linear C 1-C 10 or branched C 3-C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:i) -O-R 3ii) -S-R 3;- R 2 denotes a radical chosen from:a) a hydrogen atom;b) a saturated hydrocarbonated group linear C 1-C 12 or branched C 3-C 12 or cyclic C 3-C 8, optionally substituted with one or more groups, which may be identical or different, chosen from:i) -O-R 3ii) -S-R 3iii) -C (O) -O-R 3;iv) a C 5-C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1-C 8 alkoxy radicals;c) a C 5-C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1-C 8 alkoxy radicals- R 3 denotes a radical chosen from:a) a hydrogen atom;b) a saturated linear C 1-C 10 or branched C 3-C 10 alkyl group;B) an antioxidant, comprising vitamin C or a stabilized derivative thereof, selected from the group consisting of ascorbic acid, erythorbic acid, sodium ascorbate/erythorbate, tetrahexyl decyl ascorbate/erythorbate, ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl glucoside, glucosamine ascorbate, and ascorbyl acetate, in an amount of 15%to 30%by weight of the composition.
- The composition according to claim 1, wherein:- R 1 of formula (I) and (I’) represents a hydrogen atom,or- R 1 of formula (I) and (I’) represents a linear (C 1-C 10) alkyl group or branched (C 3-C 10) alkyl group, especially a linear (C 1-C 6) alkyl group or branched (C 3-C 6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl, particularly the said alkyl group ofR 1 is not substituted.
- The composition according to any one of the preceding claims, wherein:- R 2 of formula (I) and (I’) represents a hydrogen atom;or- R 2 of formula (I) and (I’) represents a linear (C 1-C 10) alkyl group or branched (C 3-C 10) alkyl group, especially a linear (C 1-C 6) alkyl group or branched (C 3-C 6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group; the said alkyl group of R 2 being not substituted.
- The composition according to claim 1 or 2, wherein:- R 2 of formula (I) and (I’) represents a linear (C 1-C 10) alkyl group or branched (C 3-C 10) alkyl group, especially a linear (C 1-C 6) alkyl group or branched (C 3-C 6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i) , ii) , iii) and iv) as defined in claim 1, preferably the said alkyl group being substituted by one or two groups selected from i) , ii) and iii) , more preferably by one or two groups selected from i) and iii) , better substituted by one group iii) as carboxy.
- The composition according to claim 1 or 2, wherein- R 2 of formula (I) and (I’) represents a (C 3-C 8) cycloalkyl group, preferably a (C 5-C 7) cycloalkyl group such cyclohexyl;or- R 2 of formula (I) and (I’) represents a C 5-C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1-C 8 alkoxy radicals, preferably a phenyl group particularly not substituted.
- The composition according to any one of the preceding claims, wherein- R 3 of formula (I) and (I’) represents a hydrogen atom;or- R 3 of formula (I) and (I’) represents a saturated linear C 1-C 10 or branched C 3-C 10 alkyl group; particularly a linear (C 1-C 6) alkyl group or a branched (C 3-C 6) alkyl group, preferably (C 1-C 4) alkyl group such as methyl group.
- The composition according to any one of the preceding claims, wherein:- R 1 of formula (I) and (I’) represents a radical chosen from:a) a hydrogen atom;b) a saturated linear C 1-C 6 or branched C 3-C 6 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:i) -O-R 3ii) -S-R 3;preferably optionally substituted with one or more groups i)- R 2 of formula (I) and (I’) represents a radical chosen from:- a) a hydrogen atom;- b) a saturated hydrocarbonated group linear C 1-C 10 or branched C 3-C 10 or cyclic C 3-C 8 such as C5-C6, optionally substituted with one or more groups, which may be identical or different, chosen from:- i) -O-R 3- ii) -SR- 3- iii) -C (O) -O-R 3;- iv) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C 1-C 4 alkoxy radicals such as methoxy;- preferably substituted with one or more groups selected from i) and iii) , preferably iii) such as carboxy- R 3 of formula (I) and (I’) represents a radical chosen from:- a) a hydrogen atom;- b) a saturated linear C 1-C 6 or branched C 3-C 6 alkyl group;- preferentially, the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture;- have the following meanings:- R 1 of formula (I) and (I’) represents a radical chosen from:- a) a hydrogen atom;- b) a saturated linear C 1-C 4 or branched C 3-C 4 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from i) -OR 3, more preferably not substituted;- R 2 of formula (I) and (I’) represents a radical chosen from:- a) a hydrogen atom;- b) a saturated hydrocarbonated group linear C 1-C 10 or branched C 3-C 10 or cyclic C 3-C 8 as C5-C6, optionally substituted with one or more groups, which may be identical or different, chosen from:- i) -O-R 3- iii) -C (O) -O-R 3;- iv) a C 5-C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1-C 4 alkoxy radicals;- R 3 of formula (I) and (I’) represents a radical chosen from:- a) a hydrogen atom;- b) a saturated linear C 1-C 4 or branched C 3-C 4 alkyl group such as methyl or ethyl.
- The composition according to any one of the preceding claims, whereinthe compound of formula (I) selected out from the group consisting of the compounds 1 to 24 below and their tautomer or their salts, their optical isomers, racemates, and/or solvates suchas hydrates, alone or as a mixture, particularly compounds 1, 2, 4, 6, 7, 9, 11, 12, 14, 15, 16, 17, 18, 19, 20, or 21, morre particularly 1, 9, 16, 18, 19, 20, or 21, preferably 18, 19, 20, or 21, more preferably 20:
- The composition according to any one of the preceding claims, wherein the compound of formula (I) or (I’) is present in an amount ranging from 0.01%to 20%by weight, preferably from 0.05%to 10%by weight, or preferably from 0.1%to 5%by weight, relative to the total weight of the composition.
- The composition according to any one of the preceding claims, wherein the vitamin C or stabilized derivatives thereof is present in the composition in an amount of 15%to 20%by weight, relative to the total weight of the composition.
- The composition according to any one of the preceding claims, wherein the component B) further comprises an additional antioxidant selected from cinnamic acid or a derivative thereof; andthe additional antioxidant is present in the composition from 0%to 2%by weight, preferably 0%to 1%by weight, or preferably 0.1%to 0.5%by weight, relative to the total weight of the composition.
- Use of ascorbic acid or a stabilized derivative thereof, selected from the group consisting of ascorbic acid, erythorbic acid, sodium ascorbate/erythorbate, tetrahexyl decyl ascorbate/erythorbate, ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl glucoside, glucosamine ascorbate, and ascorbyl acetate, in an amount of at least 5%by weight relative to the final composition to be applied to keratin materials,for stabilizing the compound of formula (I) and tautomer of formula (I’) as defined in any one of claims 1 to 8, e.g., for stabilizing the compound 20.
- A non-therapeutic cosmetic process for depigmenting, lightening and/or bleaching keratin materials, preferably skin, comprising the step of:applying to the keratin substance the composition according to any one of claims 1 to 11.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/100256 WO2023245459A1 (en) | 2022-06-21 | 2022-06-21 | Anti-oxidizing composition comprising a thiopyridinone compound |
FR2207483A FR3136662A1 (en) | 2022-06-21 | 2022-07-21 | ANTIOXIDANT COMPOSITION COMPRISING A THIOPYRIDINONE COMPOUND |
PCT/US2023/025678 WO2023249912A1 (en) | 2022-06-21 | 2023-06-19 | Cosmetic composition comprising hydrophilic antioxidants and thiopyridinone compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/100256 WO2023245459A1 (en) | 2022-06-21 | 2022-06-21 | Anti-oxidizing composition comprising a thiopyridinone compound |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023245459A1 true WO2023245459A1 (en) | 2023-12-28 |
Family
ID=89190875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/100256 WO2023245459A1 (en) | 2022-06-21 | 2022-06-21 | Anti-oxidizing composition comprising a thiopyridinone compound |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3136662A1 (en) |
WO (1) | WO2023245459A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117554550B (en) * | 2023-12-29 | 2024-06-04 | 大连博源医学科技有限公司 | Liquid chromatography tandem mass spectrometry detection method for catecholamine metabolites in plasma and combined stabilizer |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020012639A1 (en) * | 1999-01-08 | 2002-01-31 | Glenn Robert Wayne | Topical compositions comprising protected functional thiols |
FR2879929A1 (en) * | 2004-02-27 | 2006-06-30 | Oreal | Tinctorial composition, useful for the dyeing of keratinous fibers in human, comprises a mixed dye comprising two different chromophores |
CN103228630A (en) * | 2010-12-14 | 2013-07-31 | 莱雅公司 | Process for depigmenting keratin materials using thiopyridinone compounds |
CN108473432A (en) * | 2015-12-18 | 2018-08-31 | 莱雅公司 | Use the method for thiopyridine ketone compound decoloration keratin material |
WO2022079122A1 (en) * | 2020-10-15 | 2022-04-21 | L'oreal | Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2141626B (en) * | 1983-04-25 | 1987-01-28 | Kao Corp | Cinnamic acid derivatives for lightening melanin pigmentation of skin |
FR2848846B1 (en) * | 2002-12-18 | 2005-01-28 | Oreal | COSMETIC USE OF ASCORBIC ACID DERIVATIVES AS BLANCHING AGENTS |
WO2022138471A1 (en) * | 2020-12-22 | 2022-06-30 | L'oreal | Stabilization of thiopyridinone compound and yellowing reduction of composition comprising same |
-
2022
- 2022-06-21 WO PCT/CN2022/100256 patent/WO2023245459A1/en unknown
- 2022-07-21 FR FR2207483A patent/FR3136662A1/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020012639A1 (en) * | 1999-01-08 | 2002-01-31 | Glenn Robert Wayne | Topical compositions comprising protected functional thiols |
FR2879929A1 (en) * | 2004-02-27 | 2006-06-30 | Oreal | Tinctorial composition, useful for the dyeing of keratinous fibers in human, comprises a mixed dye comprising two different chromophores |
CN103228630A (en) * | 2010-12-14 | 2013-07-31 | 莱雅公司 | Process for depigmenting keratin materials using thiopyridinone compounds |
CN108473432A (en) * | 2015-12-18 | 2018-08-31 | 莱雅公司 | Use the method for thiopyridine ketone compound decoloration keratin material |
CN114533579A (en) * | 2015-12-18 | 2022-05-27 | 莱雅公司 | Process for bleaching keratin materials using thiopyridone compounds |
WO2022079122A1 (en) * | 2020-10-15 | 2022-04-21 | L'oreal | Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads |
Also Published As
Publication number | Publication date |
---|---|
FR3136662A1 (en) | 2023-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4757262B2 (en) | Skin external preparation containing phosphorylated saccharide | |
KR20190051350A (en) | cosmetic composition for skin aging and moisturizing including extract of Jejudo hydrangea | |
JP5363800B2 (en) | Hair restorer composition | |
KR102301123B1 (en) | Cosmetic composition comprising retiniol steblized by mixed antioxidant | |
WO2023245459A1 (en) | Anti-oxidizing composition comprising a thiopyridinone compound | |
JP2023164933A (en) | External composition containing ascorbic acid and/or salt thereof | |
KR20190071883A (en) | Cosmetic composition for prevention of skin-wrinkle containing low-molecular weight peptide through microbial fermentation of bilberry fruit | |
KR102463131B1 (en) | Composition containing aha, urea, and niacinamide for softening and whitening stratum corneum | |
KR20090009054A (en) | Cosmetic composition comprising nanovesicle vitatox which having the effect of anti-oxidation and the effect of anti- wrinkle around the eye | |
JP7267657B1 (en) | Ascorbic acid derivatives or salts thereof and cosmetics thereof | |
KR101776692B1 (en) | Composiitn for skin whitening comprising extract of Osmanthus heterophylla | |
KR102310366B1 (en) | Skin external composition for anti-aging comprising cyanidin-3-o-glucoside and natto gum | |
JP4285939B2 (en) | Topical skin preparation | |
KR101897570B1 (en) | Composition for anti-wrinkle comprising handroanthus impetiginosus extract and method for preparing the extract | |
KR20100029114A (en) | Cosmetic composition for improving skin wrinkle comprising arctigenin or arctigenin derivatives as active ingredient | |
KR20040087644A (en) | Cosmetic Composition Comprising Pyrus communis L. Extract for Skin Whitening | |
WO2023249912A1 (en) | Cosmetic composition comprising hydrophilic antioxidants and thiopyridinone compounds | |
KR102533787B1 (en) | Antioxidant effect on flavonoids and polyphenols of Ceratopteris thalictroides extract, and cosmetic composition for preventing skin aging, or for preventing or improving skin wrinkles | |
KR20100052092A (en) | Skin whitening cosmetics | |
KR100427556B1 (en) | Makeup composition containing rucinol | |
KR100678865B1 (en) | Cosmetic composition for skin whitening comprising ramulus mori extract and carnitine as active ingredient | |
KR100570096B1 (en) | Cosmetic Compostion for Preventing Skin Aging Comprising Nanoliposome Incorporating a Combined Extract of Oriental Medicines Containing Cervus elaphus | |
KR20130008182A (en) | A cosmetic composition containing extract of camellia sasanqua | |
KR102160306B1 (en) | skin whitening agent | |
KR102537101B1 (en) | NANO EMULSION COMPOSITION COMPRISING Squalene, COSMETIC COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREPARING SAME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22947239 Country of ref document: EP Kind code of ref document: A1 |